Poland· PL-100513732
Beyonttra
A other cardiac preparations product containing acoramidisum, registered in Poland by Bayer AG. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Acoramidisum is registered in 4 of 19 countries.
Countries holding a registration under ATC C01EB (other cardiac preparations), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Acoramidisum · ATC C01EB
4 / 19 countries
- Czechiaprice
- Ireland
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Acoramidisum
- Manufacturer
- Bayer AG
- Country
- Poland (PL)
- ATC code
- C01EB
- ATC class
- Other cardiac preparations
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin04057598029926
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acoramidisum in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAttrubyBridgeBio Pharma, Inc.
- SwitzerlandBeyonttra
- CzechiaBEYONTTRABayer AG, Leverkusen
- SpainBEYONTTRA 356 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FinlandBEYONTTRABayer AG
- FranceBEYONTTRA 356 mg, comprimé pelliculéBAYER AG (ALLEMAGNE)
- BelgiumBeyonttra 356 mgBayer
- IcelandBeyonttraBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beyonttra
- Liechtenstein · Beyonttra
- Norway · Beyonttra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0f3d2b4-d6d8-4453-8465-c2d42917c973 GET /v1/drugs/b0f3d2b4-d6d8-4453-8465-c2d42917c973?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "356 mg",
"packaging": "04057598029926 ¦ Rpz ¦ EU/1/24/1906/001 ¦ 160576\n120 tabl.",
"substance": "Acoramidisum 356 mg",
"common_name": "Acoramidisum",
"pl_product_id": "100513732",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about acoramidisum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.